Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A retrospective cohort study with adequate sample size and multivariable adjustment showing elevated kidney failure risk and mortality in HBsAg-positive donors, but limited by retrospective design, single-centre conduct, and modest effect sizes that require confirmation.
A multicenter retrospective real-world study with propensity weighting showing clinically meaningful improvements in response rates, PFS, and OS for a novel embolic agent versus standard care, but limited by retrospective design and real-world (non-randomized) conduct.
This is a comprehensive mechanistic review synthesizing preclinical and immunometabolic evidence linking macrophage metabolism to transplant outcomes, proposing therapeutic targets but reporting no original experimental or clinical data.